Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
What is Protara Therapeutics's quote symbol?
What is the 52 week high and low for Protara Therapeutics (NASDAQ: TARA)?
How much is Protara Therapeutics stock worth today?
How much is Protara Therapeutics's stock price per share?
What is Protara Therapeutics's Market Cap?